Richard S Finkel

39PUBLICATIONS

153CO-AUTHORS

Neurology and neuromuscular diseasesGene and molecular therapyNeural engineeringInfant and child healthMedical robotics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (39)

Sort by Publication Date:

|Jun 17, 2026

Ten years of disease-modifying therapy in spinal muscular atrophy: lessons learned and future directions.

|Jun 10, 2026

Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan.

|Apr 23, 2026

Author Correction: High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial.

|Feb 03, 2026

High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial.

Richard S Finkel, Thomas O Crawford, Eugenio Mercuri

|Dec 08, 2025

Intrathecal onasemnogene abeparvovec in treatment-naive patients with spinal muscular atrophy: a phase 3, randomized controlled trial.

Crystal M Proud, Dũng Chí Vũ, Jo M Wilmshurst

|Nov 25, 2025

Ad astra per aspera: treatment challenges and opportunities for children with spinal muscular atrophy and tracheostomy.

Yasemin Erbas, Richard S Finkel

Pageof 7

Frequent Collaborators

Francesco Muntoni

Davide Pareyson

Jacqueline Montes

Chiara Pisciotta

Michael E Shy

Manoj P Menezes

Mary M Reilly

Zarazuela Zolkipli-Cunningham

3 joint publications

Joshua Burns

3 joint publications

Charlotte J Sumner

Frequent Collaborators

Francesco Muntoni

Davide Pareyson

Jacqueline Montes

Chiara Pisciotta